E2F8 confers cisplatin resistance to ER+ breast cancer...

E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL

Tian, Jianjun, Lin, Yuting, Yu, Jianhua
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
92
Language:
english
Journal:
Biomedicine & Pharmacotherapy
DOI:
10.1016/j.biopha.2017.05.118
Date:
August, 2017
File:
PDF, 2.63 MB
english, 2017
Conversion to is in progress
Conversion to is failed